Erik M. van Maarseveen

Preparation and characterization of folate-targeted pEG-coated pDMAEMA-based polyplexes

Jan Hein van Steenis, Erik M. van Maarseveen, F.J. Verbaan et al. · Journal of Controlled Release · 2003 · 118 citations

Pharmacy, Molecular Pharmaceutics, Pharmaceutics +12

Fludarabine and Exposure-Targeted Busulfan Compares Favorably with Busulfan/Cyclophosphamide-Based Regimens in Pediatric Hematopoietic Cell Transplantation: Maintaining Efficacy with Less Toxicity

Imke H. Bartelink, Elisabeth M L van Reij, Corinne Gerhardt et al. · Biology of Blood and Marrow Transplantation · 2013 · 108 citations · Full text

Medicine, Hematology, Oncology +17

Impact of Medication Adherence on the Effect of Renal Denervation

Rosa L. de Jager, Esther de Beus, Martine M. A. Beeftink et al. · Hypertension · 2017 · 82 citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

Fludarabine exposure in the conditioning prior to allogeneic hematopoietic cell transplantation predicts outcomes

Jurgen Langenhorst, Charlotte van Kesteren, Erik M. van Maarseveen et al. · Blood Advances · 2019 · 76 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Population Pharmacokinetics of Fludarabine in Children and Adults during Conditioning Prior to Allogeneic Hematopoietic Cell Transplantation

Jurgen Langenhorst, Thomas P. C. Dorlo, Erik M. van Maarseveen et al. · Clinical Pharmacokinetics · 2018 · 71 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +15